BindingDB logo
myBDB logout

BDBM416565 3-(4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-2,2-dimethylpropan-1-ol::US10307425, Example 32::US10632122, Example 32

SMILES: CCOc1ccc2cc(ccc2c1)-c1nn(CC(C)(C)CO)c2ncnc(N)c12

InChI Key: InChIKey=FSWBNBURNIHVHB-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 416565   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Calmodulin-domain protein kinase 1


(Toxoplasma gondii)
BDBM416565
PNG
(3-(4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazolo...)
Show SMILES CCOc1ccc2cc(ccc2c1)-c1nn(CC(C)(C)CO)c2ncnc(N)c12
Show InChI InChI=1S/C22H25N5O2/c1-4-29-17-8-7-14-9-16(6-5-15(14)10-17)19-18-20(23)24-13-25-21(18)27(26-19)11-22(2,3)12-28/h5-10,13,28H,4,11-12H2,1-3H3,(H2,23,24,25)
PDB

UniProtKB/TrEMBL

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.20n/an/an/an/an/an/a



University of Washington

US Patent


Assay Description
Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ...


US Patent US10632122 (2020)

More data for this
Ligand-Target Pair
CAM kinase, CDPK family TgCDPK1


(Toxoplasma gondii (strain ATCC 50861 / VEG))
BDBM416565
PNG
(3-(4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazolo...)
Show SMILES CCOc1ccc2cc(ccc2c1)-c1nn(CC(C)(C)CO)c2ncnc(N)c12
Show InChI InChI=1S/C22H25N5O2/c1-4-29-17-8-7-14-9-16(6-5-15(14)10-17)19-18-20(23)24-13-25-21(18)27(26-19)11-22(2,3)12-28/h5-10,13,28H,4,11-12H2,1-3H3,(H2,23,24,25)
PDB
MMDB

KEGG

UniProtKB/TrEMBL

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.20n/an/an/an/an/an/a



University of Washington

US Patent


Assay Description
Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ...


US Patent US10307425 (2019)


BindingDB Entry DOI: 10.7270/Q2862JT9
More data for this
Ligand-Target Pair